Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of FK 506 in new-onset type I diabetes in man.

Literature DB >> 1721458

The use of FK 506 in new-onset type I diabetes in man.

P B Carroll¹, A G Tzakis, C Ricordi, H R Rilo, K Abu-Elmagd, N Murase, Y J Zeng, R Alejandro, D Mintz, T E Starzl.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Tacrolimus

Year: 1991 PMID： 1721458 PMCID： PMC2991090

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

Keyword Cloud
References

× No keyword cloud information.

31 in total

1. Partial preservation of pancreatic beta-cell function in children with diabetes.

Authors: R B Elliott; J R Crossley; C C Berryman; A G James
Journal: Lancet Date: 1981-07-04 Impact factor: 79.321

2. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus.

Authors: S Srikanta; O P Ganda; G S Eisenbarth; J S Soeldner
Journal: N Engl J Med Date: 1983-02-10 Impact factor: 91.245

3. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

Authors: S Srikanta; O P Ganda; A Rabizadeh; J S Soeldner; G S Eisenbarth
Journal: N Engl J Med Date: 1985-08-22 Impact factor: 91.245

4. Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.

Authors: V A Koivisto; A Aro; K Cantell; M Haataja; J Huttunen; S L Karonen; P Mustajoki; R Pelkonen; P Seppälä
Journal: Diabetologia Date: 1984-08 Impact factor: 10.122

The use of FK 506 in new-onset type I diabetes in man.

1. Partial preservation of pancreatic beta-cell function in children with diabetes.

2. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus.

3. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

4. Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.

5. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

6. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.

7. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.

8. Insulin antibodies in insulin-dependent diabetics before insulin treatment.

9. Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes.

10. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.